Agencourt genomic services is key collaborator in new study on breast and colon cancer genes

Cancer :: Agencourt genomic services is key collaborator in new study on breast and colon cancer genes

Agencourt Bioscience Corporation, a Beckman Coulter company, has announced that its Genomic Services were integral in a breakthrough Johns Hopkins study on the genetic code for breast and colon cancers. A recent and widely publicized report on that study, published this month in Science Express, was co-authored by James Hartigan, an Agencourt project manager. The research identifies close to 200 mutated genes, now linked to these cancers, most of which were not previously recognized as associated with tumor initiation, growth, spread or control. The study provides an understanding into disease processes and is expected to drive cancer research for years to come.

Most of the sequencing work and data generation for the study were done by Agencourt's Genomic Services, which has a long-standing relationship with the Johns Hopkins Kimmel Cancer Center scientists. Agencourt Bioscience, as a collaborator, worked closely with the study leader, Dr. Victor Velculescu.

"As a leader in the DNA sequencing industry, Agencourt's Genomic Services are effective for systematic, genome-wide projects and we are proud to have participated in this landmark study," commented Erick Suh, Genomic Services director for Agencourt. "This is the third major cancer research project* in which we have provided sequencing services. We are currently in discussions with Johns Hopkins regarding future studies and we will be forging relationships with additional leading cancer centers."

Agencourt Bioscience Corporation, a wholly owned subsidiary of Beckman Coulter, is a leading provider of nucleic acid purification products and genomic services for life science research. The company's products and services are based on the patented Agencourt SPRI(R) (Solid Phase Reversible Immobilization) paramagnetic bead-based technology.

Beckman Coulter, Inc. is a leading manufacturer of biomedical testing instrument systems, tests and supplies that simplify and automate laboratory processes. Spanning the biomedical testing continuum -- from pioneering medical research and clinical trials to laboratory diagnostics and point-of-care testing -- Beckman Coulter's 200,000 installed systems provide essential biomedical information to enhance health care around the world. The company, based in Fullerton, California, reported 2005 annual sales of $2.44 billion. For more information, visit http://www.beckmancoulter.com.

Paez et.al. "EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy." Science, 4 June 2004, 1497 - 1500.

Levine et al. "The JAK2V617F Activating Mutation Occurs in Chronic Myelomonocytic Leukemia, But Not in Acute Lymphoblastic Leukemia or Chronic Lymphocytic Leukemia." Blood, 15 November 2005, 3377-3379. Sjoblom et al. The Consensus Coding Sequences of Human Breast and Colorectal Cancers, Science, 07 September 2006.




(Cancer :: Agencourt genomic services is key collaborator in new study on breast and colon cancer genes published at SpiritIndia on Monday, October 16, 2006)

Cancer

Search more information on Cancer, Cancer books

Recently posted related articles on Cancer :

1. Liver Cancer :: Nexavar approved for patients with inoperable liver cancer
2. Cancer :: Scientific evidence of the significant anti-cancer effect of milk thistle
3. Breast Cancer :: Normal tissue not spared in new forms of breast cancer radiotherapy
4. Breast Cancer :: Drug Could Effectively Treat, Prevent the Spread of Breast Cancer
5. Oral Cancer :: USC School of Dentistry researchers discover link between oral cancer and ethnicity
6. Ovarian Cancer :: New Therapy for Patients with Platinum-Resistant Ovarian Cancer
7. Prostate Cancer :: Obesity and overweight linked to higher prostate cancer mortality
8. Cancer :: Caregivers benefit from cancer support programs, U-M study finds
9. Lung Cancer :: Tumor genome analysis unveils new insights into lung cancer
10. Cancer :: American Association for Cancer Research announces AACR Asia

Most related articles:

- Cancer :: Agencourt genomic services is key collaborator in new study on breast and colon cancer genes
- Breast cancer :: Facts about breast cancer - 11.8
- Breast cancer :: Breast cancer in men - 11.8
- Cancer :: Select chemotherapy in cancer patients after genomic test - 11.3
- Colorectal Cancer :: Red wine helps to reduce risk of colon cancer - 11.1
- Breast Cancer :: Breast cancer genes identified - 10.6
- Breast Cancer :: Update on familial breast cancer guideline - 9.6
- Colon Cancer :: Fruits and veggies not likely linked to colon cancer risk - 9.5
- Breast Cancer :: Scientists find genetic key to some breast cancers - 9.4
- Breast Cancer :: Understanding personal genetic risk for familial breast cancer eases anxieties - 9.3

Cancer - recent related articles/news stories:

- Obesity, alcohol use and smoking increase second breast cancer risk
- XMRV virus may cause prostate cancer in people
- A new therapy to cure skin cancer
- Cancer patients who are separated when diagnosed have worse survival rates
- High insulin level increases prostate cancer risk

»»   Radiography :: Eklin Medical Systems - industry's first comprehensive digital radiographic positioning guide
««   Pregnancy :: Next-generation contraceptive patch by Agile Therapeutics

Home | Cancer | Therapies | Diet | Herbs | Heart | Skin | Cosmetic Surgery | Arthritis | Allergies | Eyes | GIT | Glossary | List

AYUSH = Ayurveda - Yoga - Unani - Siddha - Homeopathy -- Health articles

The information provided on SpiritIndia.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. Spirit India comply with the HONcode principles for trustworthy health information.
Health, Business, Science, Sports, Entertainment, Technology
©2002-2009 SpiritIndia.com